Publications, Pharmaceutical

Nasal Drug Development, Trends and Challenges with Nasal Formulations

The confluence of COVID-19, growing recognition of the potential for nose-to-brain drug delivery and the recent success of rapid rescue remedies makes it an exciting time to be working in nasal drug delivery.

This Q&A considers the critical factors that influence nasal drug product development and current trends in formulation practice and science.

The need for a better understanding of precisely where to target nasal drug delivery, and how, is highlighted, along with requirements for better models of mucociliary clearance to tackle the challenge of improving retention. Going forward it is anticipated that nasal drug delivery will be used more, and for a wider range of drugs, notably vaccines and other biologics including mRNA and antibodies.

Download the Nasal Drug Delivery Q&A
Author(s): Dr Irene Rossi
25 Apr 2022

Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery

Find Out MORE ABOUT NASAL DRUG DELIVERY EXPERTISE

This Might Also Be of Interest

1 Sep 2022

Investigation of Powder Blend Uniformity and Deposition in a Nasa...

Publications, Pharmaceutical, Product Solutions, Device Innovations

Read More
1 Sep 2022

In Vitro and In Vivo Assessment of Regional Nasal Deposition usin...

Publications, Pharmaceutical, Device Innovations, Product Solutions

Read More
12 Jul 2022

Nasal Drug Delivery: Beyond Hayfever

Webinars, Pharmaceutical, Market Insights, Product Solutions, Innovation & Insights

Read More
12 Jul 2022

Digital Health and Digital Therapeutics: Where are we heading and...

Webinars, Pharmaceutical, Market Insights, Product Solutions, Device Innovations, Brand Differentiation

Read More
1 2 3 4 5 6 18

Request Access

Close

Requesting access to Nasal Drug Development, Trends and Challenges with Nasal Formulations.

  • This field is for validation purposes and should be left unchanged.
Back To Top